Dianthus Therapeutics | MGTA - Выручка от реализации





Продажи Изменить Дата
Akebia Therapeutics USD 57.62M 1.14M 2025-12
Alaunos Therapeutics USD 2K 2K 2025-03
Avita Medical AUD 17.61M 805K 2025-12
Celltrion KRW 1.24T 90B 2026-06
Cspc Pharmaceutical CNY 6.47B 355.1M 2026-03
Deva Holding AS TRY 2.32B 418.58M 2023-09
Dianthus Therapeutics USD 463K 179K 2026-03
Divis Laboratories Ltd INR 27.58B 730M 2026-06
IQVIA Holdings USD 4.37B 220M 2026-06
Kangmei Pharma CNY 1.08B 288.27M 2026-03
Knight Therapeutics CAD 133.11M 11.56M 2025-12
Laboratorios Farma EUR 448.66M 67.82M 2023-12
Medical Developments International AUD 21.57M 12.04M 2025-12
Moderna USD 100M 289M 2026-06
Neuren Pharmaceuticals AUD 42.24M 28.1M 2025-12
Organigram Holdings CAD 59.79M 3.74M 2026-03
Organon & Co USD 1.56B 100M 2026-06
Pharma Mar EUR 50M 7.1M 2026-06
Qiagen NV USD 463.12M 43.9M 2026-06
Revvity USD 729.68M 18.68M 2026-06
Sartorius EUR 911.8M 12.7M 2026-06
Sino Biopharmaceutical CNY 19.44B 5.18B 2026-06
Tectonic Therapeutic USD 0 0 2024-12
Tilray USD 217.51M 74.75M 2025-12
Viatris USD 3.76B 240M 2026-06
Xeris Pharmaceuticals USD 83.13M 2.68M 2026-03
Zealand Pharma A/S 34M 34.92M 2026-03
Zhangzhou Pientzehuang Pharmaceutical CNY 1.83B 887.63M 2026-06